Items where Author is "Kümmerle, A."

2021

Kümmerle, A. and Schmid, C. and Bernhard, S. and Kande, V. and Mutombo, W. and Ilunga, M. and Lumpungu, I. and Mutanda, S. and Nganzobo, P. and Tete, D. N. and Kisala, M. and Burri, C. and Blesson, S. and Valverde Mordt, O.. (2021) Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: report from a field study. PLoS Negl Trop Dis, 15 (11). e0009903.

Vanobberghen, F. and Lweno, O. and Kümmerle, A. and Mwebi, K. D. and Asilia, P. and Simon, B. and Mswata, S. and Schmidlin, S. and Glass, T. R. and Daubenberger, C. and Tanner, M. and Meyer-Monard, S.. (2021) Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallelgroup, open-label, randomised controlled phase 3 trial. Lancet Glob Health, 9 (2). e189-e198.

Kümmerle, A. and Sikalengo, G. and Vanobberghen, F. and Ndege, R. C. and Foe, G. and Schlaeppi, C. and Burri, C. and Battegay, M. and Paris, D. H. and Glass, T. R. and Weisser, M. and Marzolini, C. and Kiularco Study Group, . (2021) Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based study. J Antimicrob Chemother, 76 (10). pp. 2681-2689.

2017

Kümmerle, A. and Mäder, M. and Sartori, D. and Lazarova, A. and Urich, M. and Dodoo, A. and Olsson, S. and Burri, C.. (2017) Contribution of adverse events reporting of HIV antiretrovirals to vigibase : comparison between Sub-Saharan Africa and the rest of the world. Drug safety, 40 (10). pp. 987-988.

Kümmerle, A. and Sartori, D. and Maeder, M. and Lazarova, A. and Urich, M. and Dodoo, A. and Olsson, S. and Burri, C.. (2017) Spontaneous reporting characteristics of HIV antiretrovirals in vigibase: disproportionate analysis between Sub-Saharan Africa and the rest of the world. Drug safety, 40 (10). pp. 988-989.

2012

Schmid, C. and Kümmerle, A. and Blum, J. and Ghabri, S. and Kande, V. and Mutombo, W. and Ilunga, M. and Lumpungu, I. and Mutanda, S. and Nganzobo, P. and Tete, D. and Mubwa, N. and Kisala, M. and Blésson, S. and Mordt, O. V.. (2012) In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T.b. gambiense sleeping sickness. PLoS Neglected Tropical Diseases, 6 (11). e1920.

2011

Kümmerle, A. and Dodoo, A. N. O. and Olsson, S. and Van Erps J., and Burri, C. and Lalvani, P. S.. (2011) Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring. Malaria journal, Vol. 10 , 57.